Ledger.Open graph →
SEC Form D · Amendment · filed October 11, 2022

MOAT BIOTECHNOLOGY Corp

Offering
$1.5M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OKLAHOMA CITY, OK
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Philip A. Jones · Oklahoma City, OKDirectorTodd A. Foley · Oklahoma City, OKDirectorRichard A. Alvarez · Oklahoma City, OKExecTetherex Pharmaceuticals Corporation · Oklahoma City, OKPromoterScott A. Rollins · Oklahoma City, OKExec · Director · PromoterRussell A. Rother · Oklahoma City, OKExec · Director · PromoterLynne Chou O'Keefe · El Segundo, CADirectorStephen P. Lack · Houston, TXPromoterAdam Fried · Miami Beach, FLDirectorKim Rose · El Segundo, CAExec · Director · PromoterJoe Stringer · El Segundo, CAExec · Director · PromoterDavid Elrod · El Segundo, CAExecRay Kelleher · South San Francisco, CAPromoterJames Stutz · South San Francisco, CAExecSharon J. Lamb · Prospect, Grand Cayman, Cayman IslandsDirectorJoseph Dunnigan · Carlsbad, CAExec · Director · PromoterTodd Ballard · Carlsbad, CAExec · Director · PromoterGeorge A. Morgan · Charlotte, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗